Im/Tm/Tb- Investments PDF Download

Author: Reilly
Publisher:
ISBN: 9780030338120
Category :
Languages : en
Pages : 912

View

Book Description

Author: Lee B. Reichman
Publisher: CRC Press
ISBN: 0824745302
Category : Medical
Languages : en
Pages : 938

View

Book Description
This completely revised and expanded Second Edition thoroughly examines tuberculosis from historical, theoretical, and clinical perspectives, including the most current discoveries. Containing 35 revised, rewritten, rearranged, and new chapters by nationally and internationally renowned experts, the updated Second Edition presents expande

Author: Lloyd N. Friedman
Publisher: CRC Press
ISBN: 1420039954
Category : Medical
Languages : en
Pages : 535

View

Book Description
Why is tuberculosis out of control? What prompted a change in U.S. health policy? In the revised edition of the 1994 book, the editor has updated his bestseller to address the new challenge tuberculosis is presenting to both the medical community and the general public. The emphasis in the United States has changed to directly observe

Author: United States-Japan Cooperative Medical Science Program
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 358

View

Book Description

Author:
Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 368

View

Book Description

Author: Various
Publisher: Routledge
ISBN: 1136264922
Category : Business & Economics
Languages : en
Pages : 10558

View

Book Description
Current interest in the history of money and banking remains strong and it is opportune to survey developments both in the UK, USA, Europe and Asia. This set provides historical analysis which incorporates research from the early twentieth century onwards in a form that is both accessible to students of money & banking and economists, economic historians and bankers This set re-issues 38 volumes originally published between 1900 and 2000. It charts the history of early banking, discusses banking in the UK, Europe,Japan and the USA, analyses banks as multinationals, the UK mortgage market, banking policy and structure and examines specific sectors such as gilts and gold.

Author: Lloyd N. Friedman
Publisher: CRC Press
ISBN: 1351249975
Category : Medical
Languages : en
Pages : 469

View

Book Description
Entirely updated and revised, the 6th edition of Clinical Tuberculosis continues to provide the TB physician with a definitive and erudite account of the latest techniques in diagnosis, treatment and control of TB, including an overview of the latest guidelines from the CDC and WHO. With an increased emphasis on the clinical aspects and treatment, this book will be an invaluable resource to the TB practitioner in public health or clinical practice and an ideal reference to laboratory staff. Key Features Completely updated and reorganized Includes brand new chapters on radiology and an overview of the latest WHO, ATS/CDC/IDSA, ERS, NICE, CTS and IUATLD guidelines Clinically focused to provide up-to-date guidance on diagnosis, treatment and control Edited by three renowned experts in the field of tuberculosis

Author: Larry S. Schlesinger
Publisher: Taylor & Francis
ISBN: 042952420X
Category : Science
Languages : en
Pages : 175

View

Book Description
M. tuberculosis remains one of the most successful human pathogens known. The causative agent of tuberculosis, it also has a unique ability to persist for years in the infected, apparently healthy host. This dormant organism can be reactivated years, even decades later to cause tuberculosis. This book reviews the most important state-of-the-art approaches currently used to study microbe-host interactions and highlights emerging methodologies.

Author: Thomas M. Shinnick
Publisher: Springer Science & Business Media
ISBN: 3642801668
Category : Medical
Languages : en
Pages : 316

View

Book Description
Tuberculosis has plagued mankind since prehistoric times and is still an important source of morbidity and mortality, with particularly devastating effects in developing and tropical countries. Tuberculosis results from an infection with Myeo baeterium tubereu/osis, and the World Health Organization estimates that perhaps as much as one-third of the world's population or approximately 1. 9 billion persons are or have been infected with M. tubereu/osis. Each year, there are 8-10 million new cases of tuberculosis and about 3 million deaths due to it. Indeed, tuberculosis is the leading cause of death in adults due to a single infectious agent and accounts for ap proximately 26% of all preventable adult deaths in the world. In addition, tuberculosis is an enormous social and economic problem because approximately 95% of new cases occur in developing countries and because about 80% of tuberculosis cases affect persons of child-bearing age and du ring their most economically productive years (ages 15-59). Tuberculosis has also re-emerged as an important public health problem in many developed countries. For example, between 1985 and 1992, the number of tuberculosis cases reported to the United States Centers for Disease Control and Prevention increased by more than 20%. Similarly, Austria experienced a 5% increase in tuberculosis cases from 1987 to 1991, Ireland a 9% increase from 1988 to 1991, Denmark a 20% increase from 1987 to 1992, and Italy a 27% increase from 1988 to 1992.

Author: William R. Jacobs, Jr.
Publisher: John Wiley & Sons
ISBN: 1555819567
Category : Medical
Languages : en
Pages : 741

View

Book Description
Can today's innovative practices and molecular tools tame this ancient disease? One third of the world's population is infected with tuberculosis (TB), with about 10 million new cases annually. To combat TB and its agent, Mycobacterium tuberculosis, the World Health Organization launched The End TB Strategy, which aims to slash the suffering and cost of TB by 2035. This makes the second edition of Tuberculosis and the Tubercle Bacillus, edited by Jacobs, McShane, Mizrahi, and Orme, an extremely valuable resource for scientists and clinicians. The editors have gathered their colleagues from around the world to present the latest on the molecular biology of M. tuberculosis and related species, the host-pathogen interactions that enable invasion, and the host's immune response to M. tuberculosis infection. The basic, clinical, and translational research presented in this book supports the goals of WHO's End TB Strategy by driving toward the development of effective vaccines, rapid molecular diagnostics, and anti-TB drugs. Creating an effective tuberculosis vaccine. Understand the innate and adaptive immune response to M. tuberculosis infection, its study in established animal models, and how this information is being used to develop new vaccines against TB. Formulating new antituberculosis drugs. Learn the challenges and methods for evaluating new drugs in preclinical trials with a focus on drugs that work against "persisters" and those that act on the electron transport complex and ATP synthase of M. tuberculosis. Overcoming the challenges of diagnosing tuberculosis. Review new diagnostic tools that are simple, rapid, affordable, specific, sensitive, and safe, including molecular-based diagnostic methods such as GeneXpert MTB/RIF. Using molecular, genomic, and bioinformatics tools to understand the biology and evolution of Mycobacterium. Explore current research on the molecular mechanisms that M. tuberculosis uses to evade the immune system, enter a state of nonreplicating persistence, and become reactivated. The second edition of Tuberculosis and the Tubercle Bacillus presents the latest research on a microorganism that is exquisitely well adapted to its human host. This pathogen continues to confound scientists, clinicians, and public health specialists, who will all find much valuable information in this comprehensive set of reviews.